Skip to content
SentinelMarket desk
Switch to dark mode

파로스아이바이오

388870KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

6,240KRWMarket close of 10/21 (Wed)

Up +1.13%+70KRWMarket close of 10/21 (Wed)

Open
6,350
High
6,420
Low
6,100
Day range
Day range low 6,100 high 6,420, open 6,350, close 6,240, previous close 6,170
Volume
2×10K shares
146.88 million KRW 0.45× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 4,310 to 11,620 won, 26% up from the low

26% of the way up from the lowest close in 1 year (252 sessions) · -46.3% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-10.6B KRWOperating income over the last four quarters -10.6B KRW (loss)Operating income, 8 quarters
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move+1.13%usual range
  • Trading value0.5×usual range
  • Data date10/21 (Wed)Market close
See the full check report

Quarterly results · Q2 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Operating income-2.3B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Still a loss
    vs. prior quarter
    Still a loss

Quarterly operating income trend

As of the latest official close · 2026-10-21Valuation filing date · 2026-08-13
2023Q3 -3.1B KRW2026Q2 -2.3B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 바이오 R&D

Up +3.03%

· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -5.5%Up +3.90%60.7B KRW
올릭스Close over the last 20 sessions -6.4%Up +9.53%26.1B KRW
디앤디파마텍Close over the last 20 sessions -6.0%Up +6.65%22.0B KRW
리가켐바이오Close over the last 20 sessions -14.3%Up +2.00%12.9B KRW
프로티나Close over the last 20 sessions +35.7%Up +7.23%11.0B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 25 days
  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.